Phenotype for activated tissue macrophages in histiocytic necrotizing lymphadenitis.
Macrophage polarization is divided into M1 and M2 type based on membrane receptors, cytokines, and chemokines. M1 expresses CD80, interleukin (IL)-6, IL-12, and chemokine receptor (CCR)7, while M2 expresses CD163, IL10, and chemokine ligand (CCL)22. The aim of the present study was to identify the properties of infiltrating tissue macrophages in histiocytic necrotizing lymphadenitis (HNL). Twenty patients with HNL were studied, and immunohistochemistry for CD68 (KP1), CD163, CCL22, CCR7, and CD123 was done, along with myeloperoxidase (MPO). To evaluate the phenotypes of tissue macrophages in HNL, the number of cells stained positively for CD163, CCL22, CCR7, CD123 and MPO concurrently with CD68 was counted, and the ratio was calculated for each antibody to CD68+ cells. There was a high rate of co-expression for CD163 (median, 78%) or CCL22 (80%) and a low rate for CCR7 (5%) in CD68+ cells. It is therefore conceivable that infiltration by M2 macrophages is dominant in HNL. Furthermore, some CD68+ tissue macrophages in HNL co-express MPO or CD123 (range, 5-80%; median, 23% and 40%, respectively). It is suggested that these characteristic tissue macrophages may be associated with the pathogenesis of HNL and that M2 macrophages may infiltrate to repair the lymphoid tissue injured by cytotoxic T cells in HNL.
Nomura
Yuko
Y
Department of Pathology, School of Medicine, Kurume University, Kurume 830-0011, Japan. yuko-nomura@mvj.biglobe.ne.jp
Takeuchi
Masanori
M
Yoshida
Shiro
S
Sugita
Yasuo
Y
Niino
Daisuke
D
Kimura
Yoshizo
Y
Shimizu
Kei
K
Aoki
Ryosuke
R
Suefuji
Nobuko
N
Hirose
Shinichi
S
Kikuchi
Masahiro
M
Ohshima
Koichi
K
D000293:Adolescent; D000328:Adult; D015703:Antigens, CD / Q000378:metabolism; D015214:Antigens, Differentiation, Myelomonocytic / Q000378:metabolism; D015415:Biomarkers / Q000378:metabolism; D002648:Child; D005260:Female; D020042:Histiocytic Necrotizing Lymphadenitis / Q000276:immunology / Q000378:metabolism / Q000473:pathology*; D006801:Humans; D007150:Immunohistochemistry; D053650:Interleukin-3 Receptor alpha Subunit / Q000378:metabolism; D008198:Lymph Nodes / Q000276:immunology / Q000378:metabolism / Q000473:pathology*; D008264:Macrophages / Q000276:immunology / Q000378:metabolism / Q000473:pathology*; D008297:Male; D008875:Middle Aged; D009195:Peroxidase / Q000378:metabolism; D010641:Phenotype; D055815:Young Adult; D000097382:CD68 Molecule
D015703:Antigens, CD; D015214:Antigens, Differentiation, Myelomonocytic; D015415:Biomarkers; D053650:Interleukin-3 Receptor alpha Subunit; D009195:Peroxidase; C067980:CD68 antigen, human; D000097382:CD68 Molecule; C115022:IL3RA protein, human